Tissue therapies posts small loss

By Renate Krelle
Thursday, 10 February, 2005

Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.

At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.

It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.

Related News

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd